FTC settlements may fall short of curbing pharmacy benefit managers

FTC settlements with Express Scripts and CVS Caremark target rebate practices, formularies and pharmacy payments linked to high drug costs. A health law analysis says the agreements may leave employers and PBMs ways to avoid key restrictions, while conflicts involving private-label biosimilars remain unresolved. The outcome could shape patients’ out-of-pocket costs, drug access and competition.

Read the full article here